Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Medicine / 醫學系
  4. The Asia-Pacific consensus on ulcerative colitis
 
  • Details

The Asia-Pacific consensus on ulcerative colitis

Journal
Journal of Gastroenterology and Hepatology (Australia)
Journal Volume
25
Journal Issue
3
Pages
453-468
Date Issued
2010
Author(s)
Ooi C.J.
Fock K.M.
Makharia G.K.
Goh K.L.
Ling K.L.
Hilmi I.
Lim W.C.
Kelvin T.
Gibson P.R.
Gearry R.B.
Ouyang Q.
Sollano J.
Manatsathit S.
Rerknimitr R.
SHU-CHEN WEI  
Leung W.K.
De Silva H.J.
Leong R.W.
DOI
10.1111/j.1440-1746.2010.06241.x
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-77649226304&doi=10.1111%2fj.1440-1746.2010.06241.x&partnerID=40&md5=c496a09596af1f48a9d5959488006233
https://scholars.lib.ntu.edu.tw/handle/123456789/565711
Abstract
Inflammatory bowel disease (IBD) is increasing in many parts of the Asia-Pacific region. There is a need to improve the awareness of IBD and develop diagnostic and management recommendations relevant to the region. This evidence-based consensus focuses on the definition, epidemiology and management of ulcerative colitis (UC) in Asia. A multi-disciplinary group developed the consensus statements, reviewed the relevant literature, and voted on them anonymously using the Delphi method. The finalized statements were reviewed to determine the level of consensus, evidence quality and strength of recommendation. Infectious colitis must be excluded prior to diagnosing UC. Typical histology and macroscopic extent of the disease seen in the West is found in the Asia-Pacific region. Ulcerative colitis is increasing in many parts of Asia with gender distribution and age of diagnosis similar to the West. Extra-intestinal manifestations including primary sclerosing cholangitis are rarer than in the West. Clinical stratification of disease severity guides management. In Japan, leukocytapheresis is a treatment option. Access to biologic agents remains limited due to high cost and concern over opportunistic infections. The high endemic rates of hepatitis B virus infection require stringent screening before initiating immune-suppressive agents. Vaccination and prophylactic therapies should be initiated on a case-by-case basis and in accordance with local practice. Colorectal cancer complicates chronic colitis. A recent increase in UC is reported in the Asia-Pacific region. These consensus statements aim to improve the recognition of UC and assist clinicians in its management with particular relevance to the region. ? 2010 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
Subjects
Asia Pacific; Biologic agents; Consensus statements; Delphi; Diagnosis; Epidemiology; Inflammatory bowel disease; Leukocytapheresis; Management; Ulcerative colitis
SDGs

[SDGs]SDG3

Other Subjects
6 mercaptopurine derivative; adalimumab; antibiotic agent; antivirus agent; azathioprine; BCG vaccine; corticosteroid; cyclosporin A; ganciclovir; hydrocortisone; infliximab; isoniazid; mercaptopurine; mesalazine; methotrexate; methylmercaptopurine; methylprednisolone; nucleoside; nucleoside analog; placebo; prednisolone; salazosulfapyridine; steroid; tacrolimus; thalidomide; thiopurine methyltransferase; tioguanine; tumor necrosis factor inhibitor; unclassified drug; ursodeoxycholic acid; biological product; immunosuppressive agent; aplastic anemia; Asia; chemoprophylaxis; clinical feature; clinical trial; colitis; colon biopsy; colon resection; colonoscopy; colorectal cancer; continuous infusion; cytapheresis; cytomegalovirus infection; differential diagnosis; disease course; drug efficacy; drug mechanism; drug megadose; drug safety; environmental factor; gastrointestinal dysplasia; gastrointestinal endoscopy; gingiva hyperplasia; hepatitis B; heredity; histopathology; human; hyperglycemia; hypertension; immunopathology; infection; injection site reaction; leukopenia; liver toxicity; low drug dose; morbidity; nephrotoxicity; neurologic disease; nonhuman; prevalence; primary sclerosing cholangitis; priority journal; proctitis; proctocolectomy; quality of life; review; seizure; serum sickness; sex ratio; single drug dose; treatment response; tremor; tuberculosis; ulcerative colitis; unspecified side effect; Article; colorectal cancer; consensus; Delphi study; disease classification; disease severity; endemic disease; epidemic; gender; hepatitis B; Japan; opportunistic infection; Pacific islands; primary sclerosing cholangitis; ulcerative colitis
Publisher
Blackwell Publishing
Type
review

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science